chr12-53328314-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001173467.3(SP7):āc.1128T>Cā(p.His376=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.992 in 1,611,130 control chromosomes in the GnomAD database, including 792,947 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.96 ( 70117 hom., cov: 33)
Exomes š: 1.0 ( 722830 hom. )
Consequence
SP7
NM_001173467.3 synonymous
NM_001173467.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.955
Genes affected
SP7 (HGNC:17321): (Sp7 transcription factor) This gene encodes a member of the Sp subfamily of Sp/XKLF transcription factors. Sp family proteins are sequence-specific DNA-binding proteins characterized by an amino-terminal trans-activation domain and three carboxy-terminal zinc finger motifs. This protein is a bone specific transcription factor and is required for osteoblast differentiation and bone formation.[provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 12-53328314-A-G is Benign according to our data. Variant chr12-53328314-A-G is described in ClinVar as [Benign]. Clinvar id is 285779.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-53328314-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.955 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SP7 | NM_001173467.3 | c.1128T>C | p.His376= | synonymous_variant | 3/3 | ENST00000536324.4 | |
SP7 | NM_152860.2 | c.1128T>C | p.His376= | synonymous_variant | 2/2 | ||
SP7 | NM_001300837.2 | c.1074T>C | p.His358= | synonymous_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SP7 | ENST00000536324.4 | c.1128T>C | p.His376= | synonymous_variant | 3/3 | 2 | NM_001173467.3 | P1 | |
SP7 | ENST00000303846.3 | c.1128T>C | p.His376= | synonymous_variant | 2/2 | 1 | P1 | ||
SP7 | ENST00000537210.2 | c.1074T>C | p.His358= | synonymous_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.958 AC: 145668AN: 152114Hom.: 70068 Cov.: 33
GnomAD3 genomes
AF:
AC:
145668
AN:
152114
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.989 AC: 243542AN: 246302Hom.: 120587 AF XY: 0.992 AC XY: 132526AN XY: 133630
GnomAD3 exomes
AF:
AC:
243542
AN:
246302
Hom.:
AF XY:
AC XY:
132526
AN XY:
133630
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.995 AC: 1451771AN: 1458898Hom.: 722830 Cov.: 74 AF XY: 0.996 AC XY: 722489AN XY: 725512
GnomAD4 exome
AF:
AC:
1451771
AN:
1458898
Hom.:
Cov.:
74
AF XY:
AC XY:
722489
AN XY:
725512
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.958 AC: 145777AN: 152232Hom.: 70117 Cov.: 33 AF XY: 0.959 AC XY: 71359AN XY: 74442
GnomAD4 genome
AF:
AC:
145777
AN:
152232
Hom.:
Cov.:
33
AF XY:
AC XY:
71359
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3458
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Osteogenesis imperfecta type 12 Benign:3
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | Nov 19, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 20, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at